Source: FierceBiotech

MedyMatch: FDA puts MedyMatch image analysis software on fast track

MedyMatch Technology's intracranial hemorrhage detection software has landed a spot on the FDA's expedited access pathway. The designation sets MedyMatch up to receive advice from the FDA as it goes about advancing the software toward a filing for approval.

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
Gene Saragnese's photo - Chairman & CEO of MedyMatch

Chairman & CEO

Gene Saragnese

CEO Approval Rating

50/100

Read more